Source:http://linkedlifedata.com/resource/pubmed/id/20456708
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
2010-11-2
|
pubmed:abstractText |
Pathogen reduction technologies (PRTs) may induce storage lesion in platelet (PLT) concentrates. To investigate this, buffy coat PLTs (BCPs) in PLT additive solution (AS; SSP+) with or without Mirasol PRT (CaridianBCT Biotechnologies) were assessed by quality control tests and four-color flow cytometry.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1537-2995
|
pubmed:author | |
pubmed:copyrightInfo |
© 2010 American Association of Blood Banks.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
50
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2210-9
|
pubmed:meshHeading |
pubmed-meshheading:20456708-Blood Buffy Coat,
pubmed-meshheading:20456708-Blood Platelets,
pubmed-meshheading:20456708-Blood Preservation,
pubmed-meshheading:20456708-Blood-Borne Pathogens,
pubmed-meshheading:20456708-Flow Cytometry,
pubmed-meshheading:20456708-Humans,
pubmed-meshheading:20456708-Photosensitizing Agents,
pubmed-meshheading:20456708-Riboflavin,
pubmed-meshheading:20456708-Ultraviolet Rays
|
pubmed:year |
2010
|
pubmed:articleTitle |
In vitro cell quality of buffy coat platelets in additive solution treated with pathogen reduction technology.
|
pubmed:affiliation |
Section for Transfusion Medicine, Capital Region Blood Bank, Department of Clinical Immunology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. sisse.ostrowski@gmail.com
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|